Julia Vaamonde Gamo-rekin lankidetzan egindako argitalpenak (26)

2021

  1. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

    Journal of Parkinson's Disease, Vol. 11, Núm. 1, pp. 187-198

2009

  1. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124

2006

  1. Creación y protocolo de seguimiento longitudinal de una cohorte multipropósito de pacientes con enfermedad de Parkinson de reciente diagnóstico: Proyecto VIP

    Revista de Neurologia, Vol. 43, Núm. 6, pp. 366-373

2005

  1. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

1994

  1. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease

    Journal of Neurology Neurosurgery and Psychiatry, Vol. 57, Núm. 5, pp. 562-566

1993

  1. Clinical, kinetic, pharmacodynamic and endocrinological studies in parkinsonian patients with subcutaneous lisuride infusion

    New Trends in Clinical Neuropharmacology, Vol. 7, Núm. 4, pp. 155-165

1992

  1. FLUCTUACIONES MOTORAS EN LA ENFERMEDAD DE PARKINSON: FACTORES DE RIESGO

    Neurologia, Vol. 7, Núm. 5, pp. 89-93

  2. Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification

    Movement Disorders, Vol. 7, Núm. 2, pp. 117-124

  3. Motor response to repeated dopaminergic stimulation in Parkinson's disease

    Clinical Neuropharmacology, Vol. 15, Núm. 1, pp. 75-79

1991

  1. Subcutaneous lisuride infusion in parkinson's disease: Response TO chronic ADMINISTRATION in 34 patients

    Brain, Vol. 114, Núm. 1, pp. 601-614

1990

  1. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease

    Movement Disorders, Vol. 5, Núm. 3, pp. 260-262

  2. Generalized reflex myoclonus in a patient with alcohol‐sensitive spontaneous myoclonus and an abnormal gait

    Movement Disorders, Vol. 5, Núm. 1, pp. 85-88

1989

  1. Implantes cerebrales en la enfermedad de Parkinson.

    Neurologia

  2. LISURIDE POR VIA ORAL EN EL TRATAMIENTO DE FLUCTUACIONES COMPLEJAS DE LA MOVILIDAD EN LA ENFERMEDAD DE PARKINSON

    Neurologia, Vol. 4, Núm. 7, pp. 229-232

  3. Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response

    Clinical Neuropharmacology, Vol. 12, Núm. 1, pp. 46-54

  4. Levodopa consumption reduces dopaminergic receptor responsiveness in Parkinson's disease

    Clinical Neuropharmacology, Vol. 12, Núm. 4, pp. 271-284

  5. Motor complications associated with chronic levodopa therapy in Parkinson's disease

    Neurology

  6. Overcoming pharmacokinetic problems in the treatment of parkinson's disease

    Movement Disorders, Vol. 4, Núm. 1 S, pp. S70-S85

1988

  1. Continuous dopaminergic stimulation for Parkinson's disease: Facts and fancy

    Functional Neurology, Vol. 3, Núm. 4, pp. 413-427

  2. Levodopa therapy and motor fluctuations in Parkinson's disease

    Annals of Neurology